Search
Loading search results...
Search Results for "Dr. Michael Farzan: ACE2, the SARS-CoV-2 S protein, and better RBD-based vaccines"
Dr. Michael Farzan: ACE2, the SARS-CoV-2 S protein, and better RBD-based vaccines
Dr. Michael Farzan - Addressing the Coronavirus Challenge
Addressing the Coronavirus Challenge: Front Row Lecture with Michael Farzan, PhD
Dr. James E. Crowe, Jr: Human Monoclonal Antibodies for SARS-CoV-2
In vitro and in vivo characterization of novel SARS-CoV-2 protein subunit vaccine
Promega and Arctoris webinar Screen for SARS-CoV-2 Spike RBD:ACE2 inhibitor interactions
Vaccine targeting the RBD of S protein of SARS-COV-2 induces protective immunity
Dr. Menno van Zelm: B cell memory to SARS-CoV2 Nucleocapsid and Spike proteins in COVID-19 disease
Dr. Penny Moore: SARS-CoV-2 Infection and Vaccination in South Africa
Will SARS Cov-2 Become Resistant to Current Vaccines - Implications | Penny Moore, PhD
Dr. Dan Barouch: COVID-19 Vaccine Development
SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45− Precursors of Hematopoietic...